Drawing for TRANSPIREBIO

USPTO serial 97803410

TRANSPIREBIO

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ZELLNER, SIERRA E
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with TRANSPIREBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Trina A. Longo

Trina A. Longo SCHIFFRIN & LONGO, P.C.8200 GREENSBORO DRIVESUITE 900MCLEAN, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005Inhalers for medical use, sold filled with pharmaceutical preparations for the treatment of non-respiratory diseases and disorders; Inhalers for medical use, sold filled with pharmaceutical and biopharmaceutical preparations for the treatment of non-respiratory diseases and disordersACTIVE—
010Medical delivery system, apparatus, and instruments, namely, inhalers, sold empty, for the localized orally inhaled and systemic delivery of pharmaceutical preparations via orally inhaled route; Medical delivery system, apparatus, and instruments, namely, inhalers and nebulizers for medical use, sold empty, for facilitating the delivery of biological formulations, monoclonal antibodies, organic small molecule formulations, inorganic molecules formulations, peptides, proteins, oligonucleotides, RNA, DNA, vaccines, radiopharmaceuticals and nutraceuticals and combinations thereof; Medical delivery system, apparatus, and instruments, namely, inhalers for medical use, sold empty; Medical delivery system and apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for medical use, sold empty; drug delivery devices sold empty, namely, inhalersACTIVE—
021Inhalers, sold empty, not for medical or therapeutic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 12, 2026EXT5SOU EXTENSION 5 FILED—
Aug 12, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 20, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 19, 2026EX4GSOU EXTENSION 4 GRANTED—
Feb 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2026EXT4SOU EXTENSION 4 FILED—
Aug 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2025EX3GSOU EXTENSION 3 GRANTED—
Aug 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2025EXT3SOU EXTENSION 3 FILED—
Feb 12, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2025EX2GSOU EXTENSION 2 GRANTED—
Feb 11, 2025EXT2SOU EXTENSION 2 FILED—
Feb 11, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 11, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 1, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Oct 1, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2024EX1GSOU EXTENSION 1 GRANTED—
Aug 7, 2024EXT1SOU EXTENSION 1 FILED—
Aug 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Nov 14, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 14, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 14, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 30, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Oct 30, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 30, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 30, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 24, 2023DOCKASSIGNED TO EXAMINER—
Mar 11, 2023MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance